Overall rank by patents
#24,975
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 3 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
According to USPTO PatentsView, Parenteral ranks #24,975 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 3 technology areas.
USPTO PatentsView assignee plate
Corpus R24975 · US Corporation #24,975 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Packaging Technologies & Inspection, Llc (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Parenteral · this assignee
29 score
3D Lighting Innovati… · lowest
7 score
What this shows Parenteral's Innovation Score is 29.0/100 (top 71% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Parenteral Technologies, Llc is a focused PatentsView assignee: 3 CPC subclasses with 90.9% of grants classified under A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2015. By volume, Parenteral sits between Packaging Technologies & Inspection, Llc and Peptidream Inc..
Parenteral Technologies, Llc shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Packaging Technologies & Inspection, LLC
11 patents
Pandion Operations, Inc.
11 patents
Paper-Pak Industries
11 patents
Paradigm Health and Wellness
11 patents
Parker Hannifin Manufacturing Limited
11 patents
Pattern Bioscience, Inc.
11 patents
PendoTECH
11 patents
PeptiDream Inc.
11 patents
Parenteral Technologies, LLC
11 patents
What this shows Parenteral holds 11 patents at rank #24,987, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #24,987 in granted patent volume.
Other assignees with the most granted patents in Parenteral's primary technology class.
Parenteral's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 Top 71% higher than 29% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 9.1% |
| 2016 | 2 | 18.2% |
| 2017 | 2 | 18.2% |
| 2018 | 1 | 9.1% |
| 2020 | 2 | 18.2% |
| 2021 | 1 | 9.1% |
| 2022 | 2 | 18.2% |
Top 3 of 3 technology areas
Overall rank by patents
#24,975
of 50,000 tracked assignees
29.0 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.